Related references
Note: Only part of the references are listed.Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure
Hideo Nambu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Jun Yoshino et al.
CELL METABOLISM (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure
Junichi Matsumoto et al.
CIRCULATION (2018)
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
Yoichiro Otaki et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling
Shingo Takada et al.
CARDIOVASCULAR RESEARCH (2016)
Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure
Takaaki Furihata et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M. Givertz et al.
CIRCULATION (2015)
Skeletal Muscle Abnormalities in Heart Failure
Shintaro Kinugawa et al.
International Heart Journal (2015)
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
Shulin Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Febuxostat improves outcome in a rat model of cancer cachexia
Masaaki Konishi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes
Jun-xia Zhang et al.
ENDOCRINE (2015)
(Pro)renin receptor in skeletal muscle is involved in the development of insulin resistance associated with postinfarct heart failure in mice
Arata Fukushima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Exercise Intolerance in Chronic Heart Failure - Skeletal Muscle Dysfunction and Potential Therapies
Koichi Okita et al.
CIRCULATION JOURNAL (2013)
Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells
Yongneng Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Inhibition of Xanthine Oxidase by Allopurinol Prevents Skeletal Muscle Atrophy: Role of p38 MAPKinase and E3 Ubiquitin Ligases
Frederic Derbre et al.
PLOS ONE (2012)
Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice
Amelie Bravard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure
Yukihiro Ohta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors
Morten Busk et al.
BMC CANCER (2011)
Hyperuricemia predicts adverse outcomes in patients with heart failure
Sanae Hamaguchi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
Angela Alexander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
Corinna Bergamini et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Xanthine Oxidase Inhibition With Febuxostat Attenuates Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
Xin Xu et al.
JOURNAL OF CARDIAC FAILURE (2008)
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure
AD Gavin et al.
HEART (2005)
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction -: A new action for an old drug?
N Engberding et al.
CIRCULATION (2004)
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure - Role of xanthine-oxidase and extracellular superoxide dismutase
U Landmesser et al.
CIRCULATION (2002)
VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release
M Madesh et al.
JOURNAL OF CELL BIOLOGY (2001)
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
TP Cappola et al.
CIRCULATION (2001)
Share Paper
